As use cases for artificial intelligence (AI) build in pharma, Amgen’s Vice President of Research Saptarsi Haldar sees a “hinge moment” for the biomedical field which produces a third of the global data generated every year.
Amgen’s Research VP On Goldilocks Viscosity, AI’s Hinge Moment
India Tech And Innovation Site To Aid R&D
Amgen’s AI model to predict proteins in the “bright Goldilocks zone of viscosity” with over 80% accuracy minus a wet lab experiment holds immense potential, VP Research Haldar said at an event as he spoke about a “hinge moment” for AI in pharma
